1. Home
  2. ELTX vs CBFV Comparison

ELTX vs CBFV Comparison

Compare ELTX & CBFV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Elicio Therapeutics Inc.

ELTX

Elicio Therapeutics Inc.

HOLD

Current Price

$11.34

Market Cap

185.4M

Sector

Health Care

ML Signal

HOLD

Logo CB Financial Services Inc.

CBFV

CB Financial Services Inc.

HOLD

Current Price

$36.23

Market Cap

174.1M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
ELTX
CBFV
Founded
2011
1901
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
185.4M
174.1M
IPO Year
2014
2014

Fundamental Metrics

Financial Performance
Metric
ELTX
CBFV
Price
$11.34
$36.23
Analyst Decision
Strong Buy
Buy
Analyst Count
3
3
Target Price
$18.00
$38.00
AVG Volume (30 Days)
123.3K
1.8K
Earning Date
05-12-2026
04-22-2026
Dividend Yield
N/A
3.12%
EPS Growth
39.29
N/A
EPS
N/A
0.73
Revenue
$2,301,000.00
$43,557,000.00
Revenue This Year
N/A
$48.93
Revenue Next Year
N/A
$7.97
P/E Ratio
N/A
$48.92
Revenue Growth
N/A
N/A
52 Week Low
$6.92
$27.11
52 Week High
$14.93
$37.75

Technical Indicators

Market Signals
Indicator
ELTX
CBFV
Relative Strength Index (RSI) 55.50 59.26
Support Level $9.63 $34.08
Resistance Level $11.47 $36.44
Average True Range (ATR) 0.98 0.55
MACD 0.10 0.12
Stochastic Oscillator 59.84 100.00

Price Performance

Historical Comparison
ELTX
CBFV

About ELTX Elicio Therapeutics Inc.

Elicio Therapeutics Inc is a clinical-stage biotechnology company advancing novel immunotherapies for the treatment of cancer, including mKRAS-positive pancreatic cancer, colorectal cancer (CRC), lung cancer, and other mKRAS-positive cancers. The Company focuses on developing effective, off-the-shelf immunotherapies using its proprietary Amphiphile (AMP) technology, which aims to enhance the education, activation, and amplification of cancer-specific T cells to promote durable cancer immunosurveillance. Its clinical pipeline includes ELI-002 7P, a lymph node-targeted cancer immunotherapy currently being evaluated in a Phase 2 study for mKRAS pancreatic ductal adenocarcinoma (PDAC), a common form of pancreatic cancer.

About CBFV CB Financial Services Inc.

CB Financial Services Incis a bank holding company headquartered in Carmichaels, Pennsylvania. The company had one reportable segment, community banking services. The Bank also has a loan production office in Allegheny County, a loan production office and a corporate center in Washington County, and an operations center in Greene County, Pennsylvania. The Bank is a community-oriented institution offering residential and commercial real estate loans, commercial and industrial loans, and consumer loans, as well as a variety of deposit products for individuals and businesses in its market area.

Share on Social Networks: